We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,704
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UEVM icon
7576
VictoryShares Emerging Markets Value Momentum ETF
UEVM
$252M
$3K ﹤0.01%
+58
New +$2.92K
UITB icon
7577
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
$2.64B
$3K ﹤0.01%
+63
New +$3.06K
VIDI icon
7578
Vident International Equity Strategy
VIDI
$433M
$3K ﹤0.01%
134
-589
-81% -$16.3K
VSMV icon
7579
VictoryShares US Multi-Factor Minimum Volatility ETF
VSMV
$155M
$3K ﹤0.01%
+123
New +$3.4K
XT icon
7580
iShares Future Exponential Technologies ETF
XT
$3.82B
$3K ﹤0.01%
70
-215
-75% -$7.89K
YHGJ icon
7581
Yunhong Green CTI Ltd
YHGJ
$7.54M
$3K ﹤0.01%
70
+55
+367% +$2.26K
ZDGE icon
7582
Zedge
ZDGE
$38.6M
$3K ﹤0.01%
764
+36
+5% +$135
ZKIN icon
7583
ZK International Group
ZKIN
$77.4M
$3K ﹤0.01%
114
+94
+470% +$4.21K
ORKA
7584
Oruka Therapeutics
ORKA
$5.82B
$3K ﹤0.01%
+24
New +$2.82K
GRCE
7585
Grace Therapeutics
GRCE
$33.8M
$3K ﹤0.01%
94
+73
+348% +$2.81K
ABLG
7586
Abacus FCF International Leaders ETF
ABLG
$16M
$3K ﹤0.01%
+118
New +$3.21K
PAVMZ
7587
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
$3K ﹤0.01%
+9,878
New +$4.86K
DXYN
7588
DELISTED
Dixie Group Inc
DXYN
$3K ﹤0.01%
+1,352
New +$3.57K
MMAT
7589
DELISTED
Meta Materials Inc. Common Stock
MMAT
$3K ﹤0.01%
11
AVGR
7590
DELISTED
Avinger, Inc. Common Stock
AVGR
$3K ﹤0.01%
1
GGE
7591
DELISTED
Green Giant Inc. Common Stock
GGE
$3K ﹤0.01%
+1,070
New +$3.28K
SALM
7592
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$3K ﹤0.01%
527
+461
+698% +$1.76K
BETS
7593
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
0
FRTX
7594
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$3K ﹤0.01%
8
-35
-81% -$16.5K
INFI
7595
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$3K ﹤0.01%
+1,663
New +$3.36K
YVR
7596
DELISTED
Liquid Media Group Ltd. Common Shares
YVR
$3K ﹤0.01%
130
+49
+60% +$1.15K
IMBI
7597
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$3K ﹤0.01%
268
KSPN
7598
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$3K ﹤0.01%
+168
New +$3.91K
EVOP
7599
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$3K ﹤0.01%
+134
New +$2.81K
BLNKW
7600
DELISTED
Blink Charging Co. Warrant
BLNKW
$3K ﹤0.01%
1,746
-1,516
-46% -$2.21K

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,704 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.